Parallel Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $833 | Sell |
93
-43
| -32% | -$385 | ﹤0.01% | 3203 |
|
|
2025
Q1 | $1.02K | Buy |
136
+43
| +46% | +$323 | ﹤0.01% | 3101 |
|
|
2024
Q4 | $699 | Sell |
93
-31
| -25% | -$233 | ﹤0.01% | 3147 |
|
|
2024
Q3 | $942 | Buy |
124
+31
| +33% | +$235 | ﹤0.01% | 3039 |
|
|
2024
Q2 | $575 | Buy |
+93
| New | +$575 | ﹤0.01% | 3059 |
|
|
2023
Q4 | – | Sell |
-40
| Closed | -$283 | – | 3321 |
|
|
2023
Q3 | $283 | Buy |
40
+13
| +48% | +$92 | ﹤0.01% | 3193 |
|
|
2023
Q2 | $190 | Buy |
+27
| New | +$190 | ﹤0.01% | 3240 |
|
|
2022
Q4 | – | Sell |
-10
| Closed | – | – | 3351 |
|
|
2022
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 3121 |
|
|
2022
Q2 | – | Sell |
-9
| Closed | – | – | 2983 |
|
|
2022
Q1 | $0 | Buy |
+9
| New | – | ﹤0.01% | 2961 |
|
|
2021
Q4 | – | Sell |
-18
| Closed | – | – | 3075 |
|
|
2021
Q3 | $0 | Buy |
+18
| New | – | ﹤0.01% | 3051 |
|